Massachusetts Surveillance of Opioid-involved Morbidity and Mortality Northeast Epidemiology Conference Northampton, MA October 20, 2017 Stefanie Albert, MPH Anna Agan, MPH Office of Integrated Surveillance and Informatics Services Office of Statistics and Evaluation Bureau of Infectious Disease and Laboratory Sciences Bureau of Community Health and Prevention Massachusetts Department of Public Health Massachusetts Department of Public Health
Drug Deaths: A National Epidemic 2 Source: The New York Times, 6/5/2017
Impact on Massachusetts Source: MDPH Data Brief, August 2017 3
Impact on Massachusetts Source: MA Chapter 55 Overdose Report, August 2017 4
Enhanced State Opioid Overdose Surveillance (ESOOS) Grant GOALS Increase the timeliness of reporting non- fatal and fatal opioid overdoses and associated risk factors Disseminate surveillance findings to key stakeholders Share data with the CDC to support improved multi-state surveillance of and response to opioid-involved overdoses 5
ESOOS: Data Sources Massachusetts Ambulance Trip Record Information System (MATRIS) ESSENCE – Emergency Department Syndromic Surveillance (SyS ED) State Unintentional Drug Overdose Reporting System (SUDORS) 6
ESOOS: Data Sources ESSENCE SUDORS MATRIS • • 63 facilities, ~85% of all Combines information • Ambulance services MA ED visits from the death across all of the certificate, medical Commonwealth are • Available data includes examiner records, law reporting free-text and coded data enforcement reports, on patient demographics • Opioid definition has past medical history, and clinical information, several priority levels and toxicology reports encounter details such as for all deaths in • Available data includes patient stated chief Massachusetts patient demographics, complaint, disposition clinical information, • Has capability be • Limitations: geographic incident details such as modified to address capture, variations in text narrative, location, emerging issues and coded data date/time, disposition • Limitations: only six • Limitations: timeliness months of complete of data submission data All 3 data sources: Date/time, location, demographics 7
ESOOS: SUDORS Demographics Injury and Death Circumstances • Age • Date • Mental health and substance abuse • Sex • Location history • Race/ethnicity • Detailed toxicology • Current/ever • City and country of • Scene evidence treated for residence • Date/time last substance abuse • Marital status known alive • Recent release • Education level • Bystanders present from an institution • Usual occupation • Naloxone • Pain treatment administration history 8
ESOOS: SUDORS 74% 13% 13% Source: MA SUDORS, September 2017 (Preliminary Data) 9
ESOOS: Non-Fatal and Fatal Opioid Overdoses in Massachusetts, 2016 2,107 Deaths* *Confirmed and estimated deaths 10,875 SyS ED visits 20,987 EMS incidents 10 Source: ESSENCE and MATRIS, July 2017 MDPH Data Brief, August 2017 (Preliminary Data)
ESOOS: Non-Fatal and Fatal Opioid Overdoses in Massachusetts, 2016 Source: ESSENCE and MATRIS, July 2017 (Preliminary Data) 11
ESOOS: Non-Fatal and Fatal Opioid Overdoses in Massachusetts, 2016 12 Source: ESSENCE and MATRIS, July 2017; MDPH Data Brief, August 2017 (Preliminary Data)
ESOOS: Non-Fatal and Fatal Opioid Overdoses in Massachusetts, 2016 13 Source: ESSENCE and MATRIS, July 2017; MDPH Data Brief, August 2017 (Preliminary Data)
Acknowledgements and Contact Information • This presentation was a collaborative effort between the Massachusetts Injury Surveillance Program and Syndromic Surveillance team • With special thanks to Dana Bernson, Mark Bova, Kate Chamberlin, Rosa Ergas, Ridgely Ficks, Cassidy Heverling, Lauren Larochelle, and Jeffrey Yu • Funded by the Centers for Disease Control and Prevention (CDC) Contact information Anna Agan, MPH anna.agan@state.ma.us Stefanie Albert, MPH stefanie.albert@state.ma.us Massachusetts Syndromic Surveillance 14 syndromic-surveillance@state.ma.us
Recommend
More recommend
